Skip to main content
. Author manuscript; available in PMC: 2017 Aug 11.
Published in final edited form as: J Neurooncol. 2014 Sep 9;121(1):53–61. doi: 10.1007/s11060-014-1606-z

Fig. 5.

Fig. 5

a Protein and mRNA EMR2 expression of U251 glioblastoma cells treated with increasing bevizcumab shown with western blot (top) and RT-PCR blot (bottom). b Protein expression of EMR2 in U87 cell lines grown in vivo with and without treatment of bevacizumab. c Quantitiative PCR data of EMR2 expression in U87 cells treated in vivo with and without bevacizumab